Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...
AlterNet on MSNOpinion
Republicans’ willingness to ignore a new threat is the real problem | Opinion
When Louise and I lived in Germany in the 1980s, we visited Neuschwanstein Castle, the fantasy palace perched on a Bavarian ...
Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback